Austen; Matthias

Patent Applications and Registrations

Patent applications and USPTO patent grants for Austen; Matthias.The latest application filed is for "novel neurturin conjugates for pharmaceutical use".

Company Profile

0.15.22

Austen; Matthias - Gottingen DE
Austen; Matthias - Goettingen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Neurturin Conjugates For Pharmaceutical Use App 20160060317 - Austen; Matthias ; et al.	2016-03-03
Screening methods for compounds useful for treating pancreatic dysfunction Grant 9,049,849 - Dohrmann , et al. June 9, 2	2015-06-09
Neurturin conjugates for pharmaceutical use Grant 9,029,323 - Austen , et al. May 12, 2	2015-05-12
Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions Grant 8,853,193 - Heckel , et al. October 7, 2	2014-10-07
Method For Preventing And Treating Diabetes Using Neurturin App 20140274897 - Austen; Matthias ; et al.	2014-09-18
Method for promoting regeneration of pancreatic beta-cells by administering neurturin Grant 8,772,233 - Austen , et al. July 8, 2	2014-07-08
Cycloalkyl containing thienopyrimidines for pharmaceutical compositions Grant 8,754,079 - Lehmann-Lintz , et al. June 17, 2	2014-06-17
Formulation For Increasing Bioavailability Of Neurturin App 20140162948 - Harder; Friedrich ; et al.	2014-06-12
Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions Grant 8,648,068 - Lehmann-Lintz , et al. February 11, 2	2014-02-11
Novel Neurturin Conjugates For Pharmaceutical Use App 20130231283 - Austen; Matthias ; et al.	2013-09-05
Thienopyrimidines for pharmaceutical compositions Grant 8,486,953 - Austen , et al. July 16, 2	2013-07-16
Method For Preventing And Treating Diabetes Using Neurturin App 20130150293 - Austen; Matthias ; et al.	2013-06-13
Method for treating diabetes using neurturin Grant 8,399,408 - Austen , et al. March 19, 2	2013-03-19
Halogen Or Cyano Substituted Thieno [2,3-d]pyrimidines Having Mnk1/mnk2 Inhibiting Activity For Pharmaceutical Compositions App 20130065914 - Heckel; Armin ; et al.	2013-03-14
New Formulation For Increasing Bioavailability Of Neurturin App 20130053313 - Harder; Friedrich ; et al.	2013-02-28
Thienopyrimidines For Pharmaceutical Compositions App 20120128686 - Austen; Matthias ; et al.	2012-05-24
Methods For Increasing Beta Cell Mass Comprising Administering A Ra770 Polypeptide App 20110277045 - Dohrmann; Cord ; et al.	2011-11-10
Method For Preventing And Treating Diabetes Using Neurturin App 20110256113 - Austen; Matthias ; et al.	2011-10-20
Cycloalkyl Containing Thienopyrimidines For Pharmaceutical Compositions App 20110217311 - LEHMANN-LINTZ; Thorsten ; et al.	2011-09-08
Heterocycloalkyl-containing Thienopyrimidines For Pharmaceutical Compositions App 20110212102 - LEHMANN-LINTZ; Thorsten ; et al.	2011-09-01
Thienopyrimidines Containing A Substituted Alkyl Group For Pharmaceutical Compositions App 20110212103 - HECKEL; Armin ; et al.	2011-09-01
Novel Neurturin Conjugates For Pharmaceutical Use App 20110003741 - Austen; Matthias ; et al.	2011-01-06
Use Of Mnk Inhibitors For The Treatment Of Alzheimer's Disease App 20100247517 - Austen; Matthias ; et al.	2010-09-30
New Formulation For Increasing Bioavailability Of Neurturin App 20090258829 - Harder; Friedrich ; et al.	2009-10-15
Method for Preventing and Treating Diabetes Using Neurturin App 20080241106 - Austen; Matthias ; et al.	2008-10-02
Use of Gsk-3 Inhibitors for Preventing and Treating Pancreatic Autoimmune Disorders App 20080207594 - Mussmann; Rainer ; et al.	2008-08-28
Method for preventing and treating diabetes using dg119 App 20070110728 - Austen; Matthias ; et al.	2007-05-17
Pancreas-specific proteins App 20050222070 - Dohrmann, Cord ; et al.	2005-10-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.